Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA

PURPOSE: This study examined 2-year outcome of consecutive therapy using entecavir (ETV) followed by telbivudine (LdT) in subjects with undetectable hepatitis B virus (HBV) DNA level and normal alanine aminotransferase level after the initial 6 months of ETV treatment. MATERIALS AND METHODS: Sixty s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong Hyun, Choi, Jong Won, Seo, Jeong Hun, Cho, Yong Suk, Won, Sun Young, Park, Byung Kyu, Jeon, Han Ho, Shin, Sang Yun, Lee, Chun Kyon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368140/
https://www.ncbi.nlm.nih.gov/pubmed/28332360
http://dx.doi.org/10.3349/ymj.2017.58.3.552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368140/
https://www.ncbi.nlm.nih.gov/pubmed/28332360
http://dx.doi.org/10.3349/ymj.2017.58.3.552

Ejemplares similares